Fig. 2.
Fig. 2. STAT3 activation in the absence of receptor tyrosines. (A) EMSA of nuclear extracts from Ba/F3 cells expressing WT G-CSF-R or mutants. Growth factor–deprived cells were incubated for 10 minutes at 37°C without factor (−) or with 100 ng/mL G-CSF (+). Nuclear extracts were prepared and incubated with32P-labeled double-stranded m67 oligonucleotide. (B) STAT3 immunoprecipitation from lysates from Ba/F3 cells expressing WT or mutant G-CSF-R proteins. Serum- and growth factor–starved cells were incubated for 10 minutes at 37°C without factor (−) or with 100 ng/mL G-CSF (+). The Western blot was hybridized with anti-phosphotyrosine antibodies 4G10, before stripping and reprobing with anti-STAT3 antibodies to confirm equal loading of STAT3. Multiple analyses of at least three independent clones of each mutant gave equivalent results.

STAT3 activation in the absence of receptor tyrosines. (A) EMSA of nuclear extracts from Ba/F3 cells expressing WT G-CSF-R or mutants. Growth factor–deprived cells were incubated for 10 minutes at 37°C without factor (−) or with 100 ng/mL G-CSF (+). Nuclear extracts were prepared and incubated with32P-labeled double-stranded m67 oligonucleotide. (B) STAT3 immunoprecipitation from lysates from Ba/F3 cells expressing WT or mutant G-CSF-R proteins. Serum- and growth factor–starved cells were incubated for 10 minutes at 37°C without factor (−) or with 100 ng/mL G-CSF (+). The Western blot was hybridized with anti-phosphotyrosine antibodies 4G10, before stripping and reprobing with anti-STAT3 antibodies to confirm equal loading of STAT3. Multiple analyses of at least three independent clones of each mutant gave equivalent results.

Close Modal

or Create an Account

Close Modal
Close Modal